Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.12.10

From GxPlex

Revision as of 15:08, 29 June 2026 by Gxplex admin (talk | contribs) (1 revision imported)
Jump to: navigation, search



Document information
Reference ICH ICH E6 Guideline R3 (2025)
Validity area ICH
Scope(s) HM
Document name ICH E6 Guideline
Version / Revision R3 (2025)
Status Current
Document type International guideline
Language(s) EN
Description GUIDELINE FOR GOOD CLINICAL PRACTICE
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Scope G
Document part III. Annex 1

2.12.10

Language EN
Original entry by Florian Adragna
Contributors
Tags (EN)
Tags (original language)
Tags (FR)
Comment Computerised systems requirements for investigators

Content

2.12.10 When using computerised systems in a clinical trial, the investigator/institution should do the following:

(a)For systems deployed by the investigator/institution, ensure that appropriate individuals have secure and attributable access;

(b)For systems deployed by the sponsor, notify the sponsor when access permissions need to be changed or revoked from an individual;

(c)For systems deployed by the investigator/institution specifically for the purposes of clinical trials, ensure that the requirements for computerised systems in section 4 are addressed proportionate to the risks to participants and to the importance of the data;

(d)Where equipment for data acquisition is provided to trial participants by the investigator, ensure that traceability is maintained and that participants are provided with appropriate training;

(e)Ensure that incidents in the use and operation of computerised systems, which in the investigator’s/institution’s judgement may have a significant and/or persistent impact on the trial data or system security, are reported to the sponsor and, where applicable, to the IRB/IEC.